Ken Johnson

Ken Johnson

Chief Tech/Sci/R&D Officer chez XERIS BIOPHARMA HOLDINGS, INC.

Fortune : 987 561 $ au 31/03/2024

61 ans
Health Technology
Health Services
Consumer Services

Postes actifs de Ken Johnson

SociétésPosteDébutFin
XERIS BIOPHARMA HOLDINGS, INC. Chief Tech/Sci/R&D Officer 01/10/2021 -

Historique de carrière de Ken Johnson

Anciens postes connus de Ken Johnson

SociétésPosteDébutFin
MERCK & CO., INC. Chief Tech/Sci/R&D Officer 01/03/2016 01/01/2017
Chief Tech/Sci/R&D Officer 01/01/2015 01/01/2016
DURATA THERAPEUTICS INC Chief Tech/Sci/R&D Officer 01/04/2012 01/03/2015
Corporate Officer/Principal 01/01/2000 01/01/2002
Chief Tech/Sci/R&D Officer 05/08/2010 -
Caremark LLC Chief Tech/Sci/R&D Officer - -
Chief Tech/Sci/R&D Officer 01/03/2017 -
General Counsel 01/03/2017 -

Formation de Ken Johnson

University of Minnesota Doctorate Degree

Statistiques

Internationale

Etats-Unis 10

Opérationnelle

Chief Tech/Sci/R&D Officer 7
Corporate Officer/Principal 1
General Counsel 1

Sectorielle

Health Technology 6
Health Services 2
Consumer Services 2

Fonctions occupées

Actives

Inactives

Sociétés cotées

Entreprise privées

Sociétés liées

Sociétés cotées2
MERCK & CO., INC.

Health Technology

XERIS BIOPHARMA HOLDINGS, INC.

Health Technology

Entreprise privées6

Health Services

Health Technology

Caremark LLC

Health Technology

Distribution Services

Health Technology

Voir les connexions sociétés